Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc. - Dividend Yieldverified

AKBA

Price:

$1.07

Market Cap:

$287.04M

Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases. The firm's leading experimental drug, vadadustat, is an oral treatment currently in Phase III clinical trials. Its purpose is to address anemia resulting from chronic kidney disease (CKD) in adult patients, encompassing both those dependent on dialysis and those who are not. Akebia also markets Auryxia, a ferric citrate product used to manage serum phosphorus levels in adult CKD patients undergoing dialysis, and to treat iron deficiency anemia in adult CKD patients who are...[Read more]

Industry

Biotechnology

IPO Date

2014-03-20

Stock Exchange

NASDAQ

Ticker

AKBA

The Dividend Yield as of June 2026 (TTM) for Akebia Therapeutics, Inc. (AKBA) is 0%

According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Akebia Therapeutics, Inc. (AKBA) Historical Dividend Yield (quarterly & annually)

How has AKBA Dividend Yield performed in the past?

The mean historical Dividend Yield of Akebia Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), AKBA's Dividend Yield was at its highest in in the June 2016 quarter at 0%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Akebia Therapeutics, Inc. (AKBA) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Akebia Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20250%0%
20240%0%
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%

Akebia Therapeutics, Inc. (AKBA) Average Dividend Yield

How has AKBA Dividend Yield performed in the past?

The current Dividend Yield of Akebia Therapeutics, Inc. (AKBA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Akebia Therapeutics, Inc. (AKBA) Dividend Yield vs. Peers

How is AKBA’s Dividend Yield compared to its peers?

Akebia Therapeutics, Inc.’s Dividend Yield is less than Corvus Pharmaceuticals, Inc. (0%), less than Prothena Corporation plc (0%), less than Olema Pharmaceuticals, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Rigel Pharmaceuticals, Inc. (0%), less than KalVista Pharmaceuticals, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Compass Therapeutics, Inc. (0%), less than 4D Molecular Therapeutics, Inc. (0%), less than Zevra Therapeutics, Inc. (0%),

Build a custom stock screener for Akebia Therapeutics, Inc. (AKBA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akebia Therapeutics, Inc. (AKBA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Akebia Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Akebia Therapeutics, Inc. (AKBA)?

What is the highest Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?

What is the 3-year average Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?

What is the 5-year average Dividend Yield for Akebia Therapeutics, Inc. (AKBA)?

How does the current Dividend Yield for Akebia Therapeutics, Inc. (AKBA) compare to its historical average?